Archangels - Making The Future

Decision Process

Assuming that the basic criteria for investment are met and that the company has decided that it is seeking equity investment then the following process will be undertaken.

  • The executive will review the business plan and let the company know  whether or not the proposal will be considered further.
  • If it is not suitable for Archangels, we will try and suggest other potential investment sources.
  • If it is considered to be suitable for further investigation, then a meeting will be held with the management team to discuss the plan and the needs of the company.
  • If there is still interest, then some basic due diligence will be undertaken and other members of the syndicate may become involved in the assessment.
  • The company will be asked to present to the Board of Archangels.
  • The investment and other resource needs of the company will be discussed and agreed and an outline deal structure will be set out.
  • Appropriate due diligence and preparation of standard investment agreements etc will commence in parallel.
  • The company will normally be asked to present to a forum of interested potential investor members.
  • A non-executive chairman and a further non-executive director will be identified and agreed with the management team.
  • Any debt or grant requirements will be finalised.
  • Completion of the investment will proceed.
  • Archangels endeavour to keep deal costs low, charging upon completion of a successful funding round a research fee to cover due diligence and the initial investment. We also use low cost standard legal agreements which keep the legal fees payable by the company for completion of an investment to a minimum. There is a modest annual fee to the companies to cover the costs of ongoing monitoring and liaison.

Latest News

Bloxx Awarded International Patents

27 Mar 2014
Bloxx Awarded International Patents for its Dynamic Real-Time Web Page Categorisation Software

Touch Bionics sales reach £12.3 million in 2013

20 Jan 2014
20 January 2014 – Touch Bionics, a provider of world-leading prosthetic technologies, today announced that preliminary results indicate the company achieved revenue growth of 23% in 2013 to reach £12.3m in total sales.

PowerPhotonic Signs Partnership Deal in Israel

25 Oct 2013
World leader in precision laser micro-optics expands presence in new markets.

Touch Bionics executive receives high Scottish honour

07 Oct 2013
Livingston, Scotland – October 5, 2013 – Touch Bionics, a provider of world-leading prosthetic technologies, is proud to announce that the company’s Chief Technical Officer, Hugh Gill, has been inducted into the Scottish Engineering Hall of Fame, taking his place alongside engineering pioneers such as James Watt and Thomas Telford.

Bloxx Announces Secure Sockets Layer Intercept (SSLI) Software Development Kit for Security Solution Providers

28 Aug 2013
Boston, Mass., (August 27, 2013) – With an increasing level of Web traffic rapidly moving to the encrypted Hypertext Transfer Protocol Secure (HTTPS) protocol, Bloxx is now offering its Secure Sockets Layer Intercept (SSLI) Software Development Kit (SDK) for security solution providers and security application developers seeking to add SSL traffic intercept capabilities to their Web content filtering, firewall or Unified Threat Management (UTM) solutions.